comparemela.com
Home
Live Updates
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results : comparemela.com
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results
Preliminary unaudited total net revenue for the fourth quarter and full year 2023 of approximately $45 million and $176 million
Preliminary unaudited net product revenue for the fourth quarter and...
Related Keywords
Maryland
,
United States
,
United Kingdom
,
Canada
,
Italy
,
Rockville
,
Spain
,
Japan
,
Japanese
,
Canadian
,
Peter Greenleaf
,
Nasdaq
,
Exchange Commission Electronic Document Gathering
,
Aurinia Pharmaceuticals Inc
,
Otsuka Pharmaceuticals Co Ltd
,
Aurinia Pharmaceuticals
,
Executive Leadership
,
Investigational New Drug
,
Fourth Quarter
,
Annual Report
,
Canadian Securities Administrator System
,
Electronic Document Analysis
,
Exchange Commission
,
Electronic Document Gathering
,
Retrieval System
,
Markets
,
comparemela.com © 2020. All Rights Reserved.